These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33371835)

  • 1. ACE2 as a Potential Target for Management of Novel Coronavirus (nCoV- 2019).
    Foroozanfar E; Forouzanfar M; Farkhondeh T; Samarghandian S; Forouzanfar F
    Curr Drug Discov Technol; 2021; 18(6):e130921189567. PubMed ID: 33371835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
    Shukla AK; Banerjee M
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scientific Hypothesis for Treatment of COVID-19's Lung Lesions by Adjusting ACE/ACE2 Imbalance.
    Ferrara F; Vitiello A
    Cardiovasc Toxicol; 2021 Jun; 21(6):498-503. PubMed ID: 33835386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections.
    Ferrara F; Vitiello A
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jul; 394(7):1589-1593. PubMed ID: 34151392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.
    Ahmad S; Waheed Y; Abro A; Abbasi SW; Ismail S
    J Mol Model; 2021 Jun; 27(7):206. PubMed ID: 34169390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection.
    Penninger JM; Grant MB; Sung JJY
    Gastroenterology; 2021 Jan; 160(1):39-46. PubMed ID: 33130103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019.
    Suh SH; Ma SK; Kim SW; Bae EH
    Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.
    Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
    Curr Top Med Chem; 2021; 21(7):571-596. PubMed ID: 33463470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on ACE2 amplification and its therapeutic potential.
    Marquez A; Wysocki J; Pandit J; Batlle D
    Acta Physiol (Oxf); 2021 Jan; 231(1):e13513. PubMed ID: 32469114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.
    Villa A; Brunialti E; Dellavedova J; Meda C; Rebecchi M; Conti M; Donnici L; De Francesco R; Reggiani A; Lionetti V; Ciana P
    Pharmacol Res; 2022 Jan; 175():105982. PubMed ID: 34798263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
    Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
    Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants.
    Ou J; Zhang Y; Wang Y; Zhang Z; Wei H; Yu J; Wang Q; Wang G; Zhang B; Wang C
    Signal Transduct Target Ther; 2022 Feb; 7(1):43. PubMed ID: 35140198
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in research on ACE2 as a receptor for 2019-nCoV.
    Wu J; Deng W; Li S; Yang X
    Cell Mol Life Sci; 2021 Jan; 78(2):531-544. PubMed ID: 32780149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.
    Pang XC; Zhang HX; Zhang Z; Rinkiko S; Cui YM; Zhu YZ
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33396184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulation of ACE2 expression in COVID-19.
    Chaudhry F; Lavandero S; Xie X; Sabharwal B; Zheng YY; Correa A; Narula J; Levy P
    Open Heart; 2020 Dec; 7(2):. PubMed ID: 33443121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
    Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D
    Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor.
    Oz M; Lorke DE; Kabbani N
    Pharmacol Ther; 2021 May; 221():107750. PubMed ID: 33275999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
    Vieira C; Nery L; Martins L; Jabour L; Dias R; Simões E Silva AC
    Curr Drug Targets; 2021; 22(3):254-281. PubMed ID: 33081670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological implications of COVID-19 in reproduction: angiotensin-converting enzyme 2 a key player.
    Sharma GT; Chandra V; Mankuzhy P; Thirupathi Y; Swain DK; Pillai H; Patel SK; Pathak M; Guttula S
    Reprod Fertil Dev; 2021 Apr; 33(6):381-391. PubMed ID: 33731252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.